The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions.
Calcium pyrophosphate crystal formation has been associated clinically with hypercalcemic states (hyperparathyroidism) and hypomagnesemia. We studied aqueous solutions at pH 7.4, 37 degrees C, [Na+] = 140 nM over a range of calcium chloride/magnesium chloride/sodium pyrophosphate concentrations to determine the effect of calcium and magnesium ions on crystal formation. We found that CPPD(T) and CPPD(M) could form under different ionic conditions. Low [Mg++] and [PPi] favoured CPPD(T) whereas higher [Mg++] and [PPi] favoured CPPD(M). At [Mg++] = 1.0 mM a calcium magnesium pyrophosphate crystal phase designated CMPP2 formed. As [Mg++] affects the crystal phase formed more than equimolar [Ca++], we conclude that ionic magnesium deficiency may be a clinically important determinant in calcium pyrophosphate dihydrate crystal formation.
D002118:Calcium / Q000494:pharmacology*; D002131:Calcium Pyrophosphate; D055598:Chemical Phenomena; D002621:Chemistry; D003460:Crystallization; D011756:Diphosphates; D008274:Magnesium / Q000494:pharmacology*; D012996:Solutions; D013997:Time Factors; D014867:Water
D011756:Diphosphates; D012996:Solutions; D014867:Water; D008274:Magnesium; D002118:Calcium; D002131:Calcium Pyrophosphate